New drug DW5524 put to the test in healthy volunteers
NCT ID NCT07349589
First seen Jan 25, 2026 · Last updated Apr 29, 2026 · Updated 18 times
Summary
This early-stage study will test the safety of a new drug, DW5524, in 48 healthy adults. Participants will receive a single dose of the drug, and researchers will monitor how the body processes it and if any side effects occur. The goal is to gather basic safety information before testing the drug in people with a specific disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chungbuk National University Hospital
Cheongju-si, South Korea
Conditions
Explore the condition pages connected to this study.